• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不孕不育治疗中的双重难题——为何我们持续移植过多胚胎?

The twin epidemic in infertility care - Why do we persist in transferring too many embryos?

作者信息

Ombelet W

机构信息

Editor-in-Chief; Genk Institute for Fertility Technology, ZOL Hospitals, Schiepse Bos 6, 3600 Genk, Belgium.

出版信息

Facts Views Vis Obgyn. 2016 Dec;8(4):189-191.

PMID:28210478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5303696/
Abstract

The epidemic of iatrogenic multiple births as a result of infertility treatment are responsible for an unacceptable high incidence of maternal, perinatal and childhood morbidity and mortality. Healthcare costs due to infertility therapy are too high and this may lead to social and political concern. The introduction of single embryo transfer (SET) was a real breakthrough, but was only accepted in most European countries and Japan. The United States, Latin America and most developing countries still have high multiple pregnancy rates. The most common argument for not performing SET are the high costs associated with ART procedures. Competition between ART centres to achieve and publish the highest success rates is another major factor. But things have changed: vitrification methods for cryopreservation are responsible for a better survival and increased success rate with frozen-embryo transfer, our knowledge to select the best embryo for SET is increasing and the growing concern of health care providers and governments can be expected in the near future. Infertility specialists are supposed to deliver healthy, preferably singleton babies at the lowest cost. Misuse of science still reveals the dark side of ART in too many centres. There is enough evidence that reimbursement policies providing accessible ART to infertile couples can decrease the potential harm from multiple pregnancies substantially unless we succeed to provide simplified IVF at affordable prices.

摘要

不孕症治疗导致的医源性多胎妊娠流行,造成了孕产妇、围产期和儿童发病率及死亡率高得令人无法接受。不孕症治疗的医疗成本过高,这可能引发社会和政治关注。单胚胎移植(SET)的引入是一项真正的突破,但在大多数欧洲国家和日本才被接受。美国、拉丁美洲和大多数发展中国家的多胎妊娠率仍然很高。不进行SET的最常见理由是辅助生殖技术(ART)程序相关的高成本。ART中心之间为实现并公布最高成功率而展开的竞争是另一个主要因素。但情况已经发生了变化:冷冻保存的玻璃化方法提高了冻融胚胎移植的存活率和成功率,我们选择最佳胚胎进行SET的知识不断增加,预计医疗服务提供者和政府在不久的将来会越来越关注这一问题。不孕症专家应以最低成本接生健康的婴儿,最好是单胎婴儿。在太多中心,科学的滥用仍然暴露出ART的阴暗面。有充分证据表明,为不孕夫妇提供可及的ART的报销政策可以大幅降低多胎妊娠的潜在危害,除非我们成功以可承受的价格提供简化的体外受精(IVF)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/690f/5303696/6ec56befbb46/FVVinObGyn-8-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/690f/5303696/6ec56befbb46/FVVinObGyn-8-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/690f/5303696/6ec56befbb46/FVVinObGyn-8-189-g001.jpg

相似文献

1
The twin epidemic in infertility care - Why do we persist in transferring too many embryos?不孕不育治疗中的双重难题——为何我们持续移植过多胚胎?
Facts Views Vis Obgyn. 2016 Dec;8(4):189-191.
2
International Committee for Monitoring Assisted Reproductive Technologies (ICMART) world report: assisted reproductive technology 2004.国际辅助生殖技术监测委员会(ICMART)世界报告:辅助生殖技术 2004 年报告。
Hum Reprod. 2013 May;28(5):1375-90. doi: 10.1093/humrep/det036. Epub 2013 Feb 26.
3
The (t)WE lab Simplified IVF Procedure: First Births after freezing/thawing.(t)WE实验室简化体外受精程序:冻融后的首例分娩。
Facts Views Vis Obgyn. 2014;6(1):45-9.
4
Trends in ectopic pregnancy rates following assisted reproductive technologies in the UK: a 12-year nationwide analysis including 160 000 pregnancies.英国辅助生殖技术后异位妊娠率的趋势:一项涵盖160000例妊娠的12年全国性分析。
Hum Reprod. 2016 Feb;31(2):393-402. doi: 10.1093/humrep/dev315. Epub 2016 Jan 2.
5
The health of children conceived by ART: 'the chicken or the egg?'.ART 受孕儿童的健康:“先有鸡还是先有蛋?”。
Hum Reprod Update. 2019 Mar 1;25(2):137-158. doi: 10.1093/humupd/dmz001.
6
Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.体外受精后胚胎移植数量指南,2006年9月,第182号
Int J Gynaecol Obstet. 2008 Aug;102(2):203-16. doi: 10.1016/j.ijgo.2008.01.007.
7
Population trends and live birth rates associated with common ART treatment strategies.与常见辅助生殖技术(ART)治疗策略相关的人口趋势和活产率
Hum Reprod. 2016 Nov;31(11):2632-2641. doi: 10.1093/humrep/dew232. Epub 2016 Sep 22.
8
Pregnancy outcomes after assisted human reproduction.人类辅助生殖后的妊娠结局
J Obstet Gynaecol Can. 2014 Jan;36(1):64-83. doi: 10.1016/S1701-2163(15)30685-X.
9
Outcomes of assisted reproductive technologies at the Nairobi In Vitro Fertilisation Centre.内罗毕体外受精中心辅助生殖技术的成果。
East Afr Med J. 2009 Apr;86(4):156-61. doi: 10.4314/eamj.v86i4.46944.
10
Assisted Reproductive Technology Surveillance — United States, 2012.辅助生殖技术监测—美国,2012 年。
MMWR Surveill Summ. 2015 Aug 14;64(6):1-29.

引用本文的文献

1
Morphological embryo selection: an elective single embryo transfer proposal.形态学胚胎选择:一项选择性单胚胎移植提议。
JBRA Assist Reprod. 2018 Mar 1;22(1):20-25. doi: 10.5935/1518-0557.20180015.

本文引用的文献

1
State of the ART: Assisted Reproductive Technologies in the United States.最新技术水平:美国的辅助生殖技术
Reprod Sci. 2016 Dec;23(12):1630-1633. doi: 10.1177/1933719116667227. Epub 2016 Sep 13.
2
Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE.2012年欧洲辅助生殖技术:欧洲人类生殖与胚胎学会(ESHRE)基于欧洲登记处得出的结果
Hum Reprod. 2016 Aug;31(8):1638-52. doi: 10.1093/humrep/dew151. Epub 2016 Jun 19.
3
Assisted reproductive techniques in Latin America: the Latin American Registry, 2013.
拉丁美洲的辅助生殖技术:2013年拉丁美洲登记处
Reprod Biomed Online. 2016 Jun;32(6):614-25. doi: 10.1016/j.rbmo.2016.02.012. Epub 2016 Mar 8.
4
Extraordinary clinical success of a single-embryo transfer policy. What comes next?单胚胎移植政策取得的非凡临床成效。接下来会怎样?
Fertil Steril. 2016 Feb;105(2):302-3. doi: 10.1016/j.fertnstert.2015.10.029. Epub 2015 Nov 14.
5
Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles-analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012.单胚胎移植政策对新鲜周期和冷冻周期围产期结局的影响——对2007年至2012年日本辅助生殖技术登记处的分析
Fertil Steril. 2016 Feb;105(2):337-46.e3. doi: 10.1016/j.fertnstert.2015.10.002. Epub 2015 Oct 27.
6
Is it justified to transfer two embryos in oocyte donation? A pilot randomized clinical trial.在卵母细胞捐赠中移植两个胚胎是否合理?一项初步随机临床试验。
Reprod Biomed Online. 2015 Aug;31(2):154-61. doi: 10.1016/j.rbmo.2015.04.013. Epub 2015 May 11.
7
Trends in perinatal health after assisted reproduction: a Nordic study from the CoNARTaS group.辅助生殖后围产期健康趋势:来自CoNARTaS小组的一项北欧研究。
Hum Reprod. 2015 Mar;30(3):710-6. doi: 10.1093/humrep/deu345. Epub 2015 Jan 20.
8
Birth and perinatal outcomes and complications for babies conceived following ART.辅助生殖技术(ART)受孕婴儿的出生及围产期结局与并发症
Semin Fetal Neonatal Med. 2014 Aug;19(4):234-8. doi: 10.1016/j.siny.2014.04.001. Epub 2014 May 17.
9
Is global access to infertility care realistic? The Walking Egg Project.全球能否实现不孕不育治疗的普及?“行走的卵子”项目。
Reprod Biomed Online. 2014 Mar;28(3):267-72. doi: 10.1016/j.rbmo.2013.11.013. Epub 2013 Dec 7.
10
Multiple gestation and infertility treatment: registration, reflection and reaction--the Belgian project.多胎妊娠与不孕治疗:登记、反思与应对——比利时项目
Hum Reprod Update. 2005 Jan-Feb;11(1):3-14. doi: 10.1093/humupd/dmh048. Epub 2004 Nov 4.